EVALUATION OF HYPERCALCEMIA DISORDER AMONG OLDER ADULTS WITH CANCER
Main Article Content
Abstract
Objectives: To evaluate the state of hypercalcemia in the older adults with cancer at the Department of Palliative Treatment, Cho Ray Hospital.
Methods: A cross-sectional, descriptive, prospective study was conducted on 46 older patients (≥ 60 years old) with cancer, at the Department of Palliative Medicine, Cho Ray Hospital from 11/2020 to 06/2021, with elevated of corrected total blood calcium concentration (>2.6 mmol/L).
Results: The prevalence of hypercalcemia in older adults with cancer was 2%, with lung tumors accounting for 17.4%, bone and liver metastases accounting for 37%. The infection rate was up to 60.9%. Most patients had impaired kidney function, glomerular filtration rate from 15 to less than 60 milliliters per minute accounted for 34.8%, glomerular filtration rate decreased significantly < 15, accounting for 58.7%. Severe progression accounted for 45.7%, mortality rate was 6.5%.
Conclusions: The prevalence of hypercalcemia in older adults with cancer was 2%, with diverse clinical features. Most of them have severe renal failure, severe clinical progression, mortality rate was 6.5%.
Keywords
Elderly, cancer, cancer-related hypercalcemia
Article Details
References
Grill V, Martin TJ. Hypercalcemia of malignancy. Reviews in Endocrine and Metabolic Disorders. 2000 Nov;1(4):253-263.
Stewart AF. Hypercalcemia associated with cancer. New England Journal of Medicine. 2005 Jan 27;352(4):373-379.
Chan JY, Kanthaya M. Hypercalcaemic crisis in an elderly patient with pulmonary tuberculosis. Oxford Medical Case Reports. 2015 Nov 1;2015(11):354-357.
Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. Journal of Clinical Oncology. 2007 May 10;25(14):1824-1831.
Lindner G, Felber R, Schwarz C, et al. Hypercalcemia in the ED: prevalence, etiology, and outcome. The American journal of emergency medicine. 2013 Apr 1;31(4):657-660.
Kuchay MS, Kaur P, Mishra SK, et al. The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study. Clinical Cases in Mineral and Bone Metabolism. 2017 May;14(2):131.
Catalano A, Chilà D, Bellone F, et al. Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? Journal of clinical & translational endocrinology. 2018 Sep 1;13:9-13.
Bhandari S, Kumar R, Tripathi P, et al. Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Medical Oncology. 2019 Oct;36(10):1-6.
Penel N, Dewas S, Doutrelant P, et al. Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis. Supportive Care in Cancer. 2008 Apr;16(4):387-392.